IDEAS home Printed from https://ideas.repec.org/p/osf/osfxxx/eyaf2_v1.html
   My bibliography  Save this paper

Preclinical Investigation of Resveratrol and CAR-Macrophage Synergy for IDH1-Mutant Glioblastoma: An AI-Driven, Multi-Scale Modelling Rationale and Protocol

Author

Listed:
  • McNab, Angus

Abstract

Glioblastoma (GBM) remains a clinical death trap with limited progress in decades and dismal survival rates. In this study, we present a computationally optimized, first-in-class therapeutic strategy combining Resveratrol and CAR-macrophages for IDH1-mutant GBM. Using an AI-driven, multi-scale modeling framework integrating ODEs, agent-based modeling, and reaction-diffusion dynamics, we simulated over 740 compute hours and 250 experimental conditions. The optimized combination achieved a predicted 93% tumor volume reduction in silico (95% CI: 90–96%, p < 0.001), far exceeding benchmarks for monotherapies or temozolomide (~30%). Synergy was driven by Resveratrol-induced metabolic reprogramming, antigen upregulation (+33% IL13Rα2/EGFR), and enhanced CAR-macrophage persistence and cytotoxicity (M1/M2 ratio 5.8:1). Monte Carlo sensitivity analysis (n=250) confirmed robustness across parameter ranges, with a peak synergy index of 2.35. This study provides a mechanistically grounded, computationally validated hypothesis for a novel, testable GBM therapy, and lays the foundation for in vitro and in vivo validation. Key model logic, simulation parameters, and setup conditions will be released upon publication to support community replication and refinement.

Suggested Citation

  • McNab, Angus, 2025. "Preclinical Investigation of Resveratrol and CAR-Macrophage Synergy for IDH1-Mutant Glioblastoma: An AI-Driven, Multi-Scale Modelling Rationale and Protocol," OSF Preprints eyaf2_v1, Center for Open Science.
    • Handle: RePEc:osf:osfxxx:eyaf2_v1
    DOI: 10.31219/osf.io/eyaf2_v1
    as

    Download full text from publisher

    File URL: https://osf.io/download/67fbfd6ff90af0bb18763b20/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/eyaf2_v1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:osfxxx:eyaf2_v1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://osf.io/preprints/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.